forgemax.FORGED. TESTED. PROVEN.
Apcalis Oral Jelly 20mg/Sachet 7 Sachets by Ajanta Pharma
Lab Tested

Apcalis Oral Jelly 20mg/Sachet 7 Sachets by Ajanta Pharma

5 (2 reviews)

Apcalis Oral Jelly delivers Tadalafil 20mg per sachet in a fast-absorbing oral jelly format, distinguished by its exceptional 36-hour duration of action — the pharmacological property that earned Tadalafil its reputation as the 'weekend pill' and separates it decisively from shorter-acting PDE5 inhibitors. Understanding this extended action window transforms how users plan intimacy: a single sachet dosed on Friday evening remains pharmacologically active through Sunday, eliminating the rigid timing pressure associated with 4–6 hour compounds. Quality assurance at the batch level is enforced through HPLC-based potency verification and LAL endotoxin testing — both conducted under WHO-GMP certified conditions at Ajanta Pharma's regulated manufacturing sites.

€22.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers a full 36-hour action window from a single 20mg sachet — no re-dosing needed across a weekend
  • Oral jelly formulation accelerates mucosal absorption, reducing onset time compared to conventional Tadalafil tablets
  • Pre-measured 20mg sachets eliminate guesswork and ensure consistent dosing aligned with clinical protocols
  • Convenient tear-open sachet packaging supports discreet, on-the-go use without requiring water
  • Produced by Ajanta Pharma under WHO-GMP conditions with HPLC batch-release testing for confirmed potency
  • Lab Tested designation reflects LAL endotoxin and microbiological safety checks at the finished-product stage
  • Jelly format is suitable for users who find tablet swallowing inconvenient or prefer faster-acting delivery systems

Key takeaways

  • Choose Tadalafil jelly for a verified 36-hour action window per sachet.
  • Dose once on Friday — remain pharmacologically covered through Sunday.
  • Expect faster onset with jelly format versus standard Tadalafil tablets.
  • Confirm 20mg as the standard on-demand clinical dose for Tadalafil.
  • Trust HPLC-verified, LAL-tested batches from a WHO-GMP certified facility.

Tadalafil's 36-Hour Action Window: The Pharmacological Basis of the 'Weekend Pill' Label

Apcalis Oral Jelly is a Tadalafil-based PDE5 inhibitor formulated as an oral jelly — a dosage form engineered for rapid buccal and gastrointestinal absorption — providing a clinically documented duration of action that reaches up to 36 hours per 20mg sachet. This extended window is not a marketing construct: it derives directly from Tadalafil's plasma half-life of approximately 17.5 hours (as reported in pharmacokinetic studies cited in the EMA assessment report for Tadalafil), which is roughly three to four times longer than Sildenafil's half-life of 3–5 hours. Compared to Sildenafil's functional action window of 4–6 hours, Tadalafil's 36-hour window gives users a fundamentally different relationship with dosing and spontaneity.

Why the Duration Gap Between PDE5 Inhibitors Actually Matters

Tadalafil selectively inhibits phosphodiesterase type 5, the enzyme responsible for degrading cGMP in penile smooth muscle tissue, thereby sustaining vasodilatory signalling for an extended period without requiring re-dosing. The jelly formulation accelerates onset: because absorption begins in the oral mucosa before gastric processing, many users report effects within 15–30 minutes — faster than standard Tadalafil tablets, which typically require 30–45 minutes. Apcalis Oral Jelly therefore combines the speed advantage of a gel-phase delivery system with the prolonged coverage unique to Tadalafil's molecular pharmacokinetics.

Planning Around a 36-Hour Window: Practical Implications

Dose Friday evening, remain covered through Sunday — this is the practical reality of Tadalafil's action window that no other mainstream PDE5 inhibitor replicates. Because the compound remains active across roughly 36 hours, users are freed from the narrow timing windows (dose 30–60 minutes before, act within 4 hours) that define shorter-acting alternatives. Apcalis Oral Jelly sachets offer a pre-measured 20mg dose — the standard clinically studied dose — eliminating the need to split tablets or estimate partial doses.

Batch-Level Quality Verification

Every Apcalis Oral Jelly batch undergoes HPLC potency assay to confirm that Tadalafil content per sachet meets pharmacopoeial specification limits; LAL endotoxin testing provides an additional sterility-adjacent safety checkpoint. These analytical procedures are executed within Ajanta Pharma's WHO-GMP certified manufacturing infrastructure, a framework that also carries facility-level recognition from international regulatory bodies.

Usage

  1. Identify your intended action window: Tadalafil's 36-hour duration means you can dose 15–30 minutes before first anticipated activity and remain covered — plan accordingly rather than timing doses immediately before each encounter.
  2. Tear open the sachet along the notch and squeeze the entire jelly contents directly onto the tongue or into the mouth — do not attempt to split the dose, as partial sachet contents cannot be resealed reliably.
  3. Allow the jelly to dissolve naturally in the mouth; swallowing is not required immediately, as buccal absorption begins on contact with the oral mucosa and contributes to faster onset.
  4. Avoid consuming large high-fat meals immediately before dosing — while Tadalafil's absorption is less food-dependent than Sildenafil's, heavy fat loads can modestly delay peak plasma concentration.
  5. Do not exceed one 20mg sachet in any 24-hour period; because the 36-hour window extends well beyond a single day, stacking doses creates unnecessary cumulative plasma exposure and elevated side-effect risk.
  6. Store remaining sachets in the original packaging below 25°C, away from humidity and direct light — optimal storage preserves both the jelly texture and Tadalafil potency across the pack's shelf life.

Warnings

Contraindications: Absolute contraindication with all nitrate-containing medications (prescribed or recreational) — combined vasodilation produces potentially life-threatening hypotension.

Contraindicated in patients with severe hepatic impairment (Child-Pugh Class C) due to significantly impaired Tadalafil clearance.

Not indicated for individuals with recent (within 90 days) myocardial infarction, unstable angina, or uncontrolled arrhythmia.

Contraindicated alongside alpha-blockers (except tamsulosin at specific doses) and other antihypertensive agents without physician evaluation.

Side Effects: Most frequently reported: headache, facial flushing, nasal congestion, and back pain — back pain is a Tadalafil-specific effect linked to PDE11 cross-reactivity and typically resolves within 48 hours.

Visual disturbances (blue-tinge, blurred vision) occur less commonly; any sudden vision loss requires immediate cessation and emergency medical evaluation.

Prolonged erection exceeding 4 hours (priapism) is rare but constitutes a medical emergency — seek immediate treatment to prevent permanent tissue damage.

Hearing changes including tinnitus or sudden hearing loss have been reported rarely with PDE5 inhibitors; discontinue and consult a physician promptly.

Monitoring: Blood pressure should be assessed before initiating Tadalafil in patients with borderline hypotension; the 36-hour duration means any hypotensive event may persist longer than with shorter-acting agents.

Renal function monitoring is advised in patients with moderate impairment — reduced creatinine clearance (<30 mL/min) significantly prolongs Tadalafil exposure beyond the standard 36-hour window.

Hepatic enzyme levels should be checked periodically in users with pre-existing liver conditions, as Tadalafil is hepatically metabolised via CYP3A4.

PCT: Tadalafil is not a hormonal compound and does not suppress the HPG axis; formal post-cycle therapy is not pharmacologically required following Tadalafil-only use.

When Apcalis Oral Jelly is used alongside anabolic compounds that cause endogenous testosterone suppression, PCT should be structured around the hormonal agents (e.g., SERMs such as Clomiphene or Tamoxifen) — not around Tadalafil itself.

Discontinuation of Tadalafil after extended use requires no taper; the compound may be stopped without washout protocol, though users should allow approximately 72 hours for full plasma clearance before any nitrate administration.

Frequently asked questions

How long does Tadalafil actually last compared to other PDE5 inhibitors?
Tadalafil's functional duration of action extends up to 36 hours, derived from its plasma half-life of approximately 17.5 hours as documented in EMA pharmacokinetic assessments. This contrasts sharply with Sildenafil's 4–6 hour window and Vardenafil's similar short window. The extended coverage means Tadalafil does not require precise pre-sex timing, offering flexibility across an entire weekend from a single 20mg dose.
Why is Tadalafil specifically called the 'weekend pill' and not other ED medications?
Tadalafil earned the 'weekend pill' label because its ~36-hour duration of action covers an entire weekend from a single Friday dose — no other widely available PDE5 inhibitor achieves this. Sildenafil and Vardenafil both carry action windows of 4–6 hours, requiring re-dosing for weekend-long coverage. Tadalafil's unique molecular structure gives it a half-life roughly 3–4 times longer, which is the direct pharmacological reason for the nickname.
Does the oral jelly form of Tadalafil work faster than a standard Tadalafil tablet?
Yes — the jelly formulation initiates absorption through the oral mucosa before gastric processing begins, which typically accelerates onset to 15–30 minutes in many users, compared to the 30–45 minutes commonly reported for standard Tadalafil tablets. The 36-hour duration of action remains the same regardless of formulation; what changes is how quickly the compound reaches effective plasma concentration after administration.
Is 20mg per sachet the standard dose for Tadalafil, and is it the lowest available strength?
20mg is the standard on-demand clinical dose for Tadalafil studied in pivotal trials, and within Ajanta Pharma's Apcalis Oral Jelly range, each sachet delivers exactly this pre-measured amount. For daily low-dose Tadalafil regimens, clinicians sometimes prescribe 2.5mg or 5mg separately — but for on-demand use, 20mg per sachet is both the standard and the entry point, making Apcalis Oral Jelly directly aligned with established dosing protocols.
How should Apcalis Oral Jelly sachets be stored, and what happens after a sachet is opened?
Unopened sachets should be stored below 25°C, away from direct sunlight and moisture. Once a sachet is torn open, the entire 20mg contents should be consumed immediately — the jelly formulation is not designed for partial dosing or re-sealing, as exposure to air and temperature fluctuation degrades the active compound. Store the remaining sealed sachets in their original box and keep away from children. (2) angle_used

Manufacturer

Apcalis Oral Jelly is a product of Ajanta Pharma Limited — a company whose commercial origins date to 1973 in Mumbai and whose subsequent four-decade expansion produced a global branded-generics business operating across more than 30 countries. What sets Ajanta Pharma's quality framework apart from routine generics manufacturers is the combination of analytical rigour applied at batch release: HPLC potency assay confirms that Tadalafil content in each Apcalis sachet falls within pharmacopoeial specification limits, while LAL endotoxin testing provides a critical safety checkpoint for the finished jelly product. This methodology is executed within manufacturing facilities that hold WHO-GMP certification; several sites additionally carry regulatory recognition from international agencies, positioning Ajanta Pharma's output within the compliance expectations of both Western regulated markets and major emerging economies. The Apcalis product line specifically represents Ajanta Pharma's Tadalafil-focused consumer offering, distinct from the broader Kamagra range, and is released to market only after passing the full validated quality-control sequence described above.

Product details

BrandAjanta Pharma
Active ingredienttadalafil citrate
Also known asTadalafil, Cialis, Tadalafil Citrate, Apcalis Oral Jelly, Ajanta Pharma Tadalafil
Strength20 mg
FormGel
Pack size7 pieces
Item numberPOT-TADA-AJA-005

Reviews

5/5

2 reviews

  • Rating: 5 out of 5 starscableguy85Verified purchase

    Proper good stuff

    Wasn't sure about the jelly format at first but honestly it kicks in faster than any tab I've tried. Maybe 20 mins and I'm sorted for the whole evening. Packaging was discreet, arrived in 4 days. Will be reordering.

  • Rating: 5 out of 5 starshydraVerified purchase

    does exactly what it says

    solid product. Onset is quick, effects last well into the next day. No headaches which I sometimes get with other brands. Good value for the quality...

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Vidalista 60 60mg/tab 100 Tablets by Centurion LaboratoriesPharma Grade

Vidalista 60 60mg/tab 100 Tabletten by Centurion Laboratories

€100.00
Vidalista 20 20mg/tab 100 Tablets by Centurion LaboratoriesHPLC Verified

Vidalista 20 20mg/tab 100 Tabletten by Centurion Laboratories

€75.00
Cialis 20mg 20mg/tab 4 Tablets by LillyPurity Tested

Cialis 20mg 20mg/tab 4 Tabletten by Lilly

€20.00
Vikalis VX 60 60mg/tab 100 Tablets by Shree VenkateshBatch Tested

Vikalis VX 60 60mg/tab 100 Tabletten by Shree Venkatesh

€80.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00